![Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma | Clinical Cancer Research Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/24/4/821/F1.large.jpg)
Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma | Clinical Cancer Research
![Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420306206-fx1.jpg)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect
![Antibodies: The major participants in maternal–fetal interaction - Yang - 2019 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library Antibodies: The major participants in maternal–fetal interaction - Yang - 2019 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/40becf42-f0ed-4417-bc18-12d08883945d/jog13839-fig-0001-m.jpg)
Antibodies: The major participants in maternal–fetal interaction - Yang - 2019 - Journal of Obstetrics and Gynaecology Research - Wiley Online Library
Reversible blocking of antibodies using bivalent peptide–DNA conjugates allows protease-activatable targeting - Chemical Science (RSC Publishing)
![Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867421001768-fx1.jpg)
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection - ScienceDirect
![Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00661-w/MediaObjects/41392_2021_661_Fig1_HTML.png)
Exploiting a chink in the armor: engineering broadly neutralizing monoclonal antibodies for SARS-like viruses | Signal Transduction and Targeted Therapy
![Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins](https://image.jimcdn.com/app/cms/image/transf/none/path/s913ff347a6964b90/image/i6682f6b7804e7d27/version/1581671872/image.gif)
Anta", "Block", "Neutra"...but Who Are They? - Innovative antibodies against haptens and transmembrane proteins
![Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development: Immunity Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development: Immunity](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119340188/2092424689/fx1.jpg)
Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development: Immunity
![Siemens Healthineers Collaboration with CDC Will Define Threshold for Neutralizing Antibody Sufficient to Confer Immunity Siemens Healthineers Collaboration with CDC Will Define Threshold for Neutralizing Antibody Sufficient to Confer Immunity](https://cdn0.scrvt.com/0e46935d037de4ec3888566275864b37/1800000007378627/19ef9c1af0cc/v/d5d1e8387ea8/siemens-healthineers-press-spike-protien-antibody-ace2-Rec-Human-cell_1800000007378627.jpg)